Dimorphic fungi: Difference between revisions
From IDWiki
(→) |
(added table) |
||
Line 1: | Line 1: | ||
+ | * Fungi that exist in a mold form at lower temperatures in the environment, and a yeast form at higher temperatures in the host body |
||
− | == Species == |
||
+ | * [[Cryptococcus]] does exhibit dimorphism, though it is predominately yeast and its dimorphism is not likely related to disease |
||
⚫ | |||
⚫ | |||
− | * ''[[Coccidioides immitis]]'' and ''[[Coccidioides posadasii]]'' |
||
− | * ''[[Cryptococcus neoformans]]'' and ''[[Cryptococcus gattii]]'' |
||
⚫ | |||
+ | {| class="wikitable" |
||
⚫ | |||
+ | !Organism |
||
⚫ | |||
+ | !Distribution |
||
+ | !Diseases |
||
+ | !Treatment |
||
+ | |- |
||
⚫ | |||
+ | |eastern US and Canada, with some reported in Africa |
||
+ | |pulmonary infection, verrucous skin lesions, osteomyelitis, CNS infection |
||
+ | |[[itraconazole]] (with [[amphotericin B]] induction if severe) |
||
+ | |- |
||
+ | |[[Coccidioides species]] |
||
+ | |southwestern US and parts of South and Central America |
||
+ | |pulmonary infection, verrucous skin lesions, osteomyelitis, CNS infection |
||
+ | |[[fluconazole]] (with [[amphotericin B]] and [[flucytosine]] induction if severe) |
||
+ | |- |
||
⚫ | |||
+ | |worldwide, including eastern North America, Central and South America, sub-Saharan Africa, and parts of Southeast Asia |
||
+ | |pulmonary infection, CNS infection |
||
+ | |[[itraconazole]] (with [[amphotericin B]] induction if severe) |
||
+ | |- |
||
+ | |[[Paracoccidioides brasiliensis]] |
||
+ | |South America |
||
+ | | |
||
+ | | |
||
+ | |- |
||
⚫ | |||
+ | |essentially worldwide |
||
+ | |[[nodular lymphangitis]] |
||
+ | |[[itraconazole]] |
||
+ | |- |
||
+ | |[[Talaromyces marneffei]] |
||
+ | |Southeast Asia |
||
+ | | |
||
+ | | |
||
+ | |} |
||
+ | <br /> |
||
⚫ | |||
+ | |||
⚫ | |||
[[File:Histoplasmosis_map.png|frame|Histoplasmosis]] |
[[File:Histoplasmosis_map.png|frame|Histoplasmosis]] |
Revision as of 14:41, 20 August 2020
- Fungi that exist in a mold form at lower temperatures in the environment, and a yeast form at higher temperatures in the host body
- Cryptococcus does exhibit dimorphism, though it is predominately yeast and its dimorphism is not likely related to disease
Organism | Distribution | Diseases | Treatment |
---|---|---|---|
Blastomyces species | eastern US and Canada, with some reported in Africa | pulmonary infection, verrucous skin lesions, osteomyelitis, CNS infection | itraconazole (with amphotericin B induction if severe) |
Coccidioides species | southwestern US and parts of South and Central America | pulmonary infection, verrucous skin lesions, osteomyelitis, CNS infection | fluconazole (with amphotericin B and flucytosine induction if severe) |
Histoplasma capsulatum | worldwide, including eastern North America, Central and South America, sub-Saharan Africa, and parts of Southeast Asia | pulmonary infection, CNS infection | itraconazole (with amphotericin B induction if severe) |
Paracoccidioides brasiliensis | South America | ||
Sporothrix schenckii | essentially worldwide | nodular lymphangitis | itraconazole |
Talaromyces marneffei | Southeast Asia |
Distribution
- Endemic dimorphic fungi are widely distributed1
References
- ^ Ashraf N, Kubat RC, Poplin V, Adenis AA, Denning DW, Wright L, McCotter O, Schwartz IS, Jackson BR, Chiller T, Bahr NC. Re-drawing the Maps for Endemic Mycoses.. Mycopathologia. 2020. doi:10.1007/s11046-020-00431-2. PMID 32040709.